1Pimenta Amaral TM, Da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP (2004). Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 40: 780–786.
2Kurokawa H, Yamashita Y, Takeda S, Zhang M, Fukuyama H, et al. (2002). Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck 24: 731–736.
3Vijayakumar M, Burrah R, Sabitha KS, Nadimul H, Rajani BC (2011) To operate or not to operate N0 neck in early cancer of the tongue? A prospective study. Indian J Surg Oncol 2: 172-175.
4Kaya S, Yilmaz T, Gürsel B, Saraç S, Sennaroglu L (2001). The value of elective neck dissection in treatment of cancer of the tongue. Am J Otolaryngol 22: 59–64.
5Qi-Gen Fang (2013). Occult Node Metastasis in Early Tongue Squamous Cell Carcinoma. Anaplastology 6 -2161-1173.
6Kalet IJ, Whipple M, Pessah S, Barker J, Austin-Seymour MM, et al. (2002). A rule- based model for local and regional tumor spread. Proc AMIA Symp 360–364.
7Geke B. Flach , Mark Tenhagen, Remco de Bree , Ruud H. Brakenhoff , Isaac van der Waal, et al. (2013). Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection. Oral Oncology 49: 157–164.
8Rory O'Connor, Tom Pezier, Clare Schilling, Mark McGurk (2013). The relative cost of sentinel lymph node biopsy in early oral cancer. J Craniomaxillofac Surg 41: 721-727.
9Paul W. Poeschl, Rudolf Seemann, Cornelia Czembirek , Guenter Russmueller, Irene Sulzbacher (2012). Impact of elective neck dissection on regional recurrence and survival in cN0 staged oral maxillary squamous cell carcinoma. Oral Oncol 48: 173–178.
10Canis M, Plüquett S, Ihler F, Matthias C, Kron M (2012). Impact of elective neck dissection vs observation on regional recurrence and survival in cN0-staged patients with squamous cell carcinomas of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 138: 650-655.
11Didier Dequanter, Philippe Lothaire (2011). Characteristics of Patients with Upstaging by Sentinel Lymph Node Biopsy of the N0 Neck in Head and Neck Cancer. Journal of Cancer Therapy. 2: 285-287.
12Wensing BM, Merkx MA, Krabbe PF, Marres HA, Van den Hoogen FJ (2011). Oral squamous cell carcinoma and a clinically negative neck: The value of follow-up. Head Neck 33: 1400–1405.
13Montes DM1, Carlson ER, Fernandes R, Ghali GE, Lubek J, et al. (2001) Oral Maxillary Squamous Carcinoma: An Indication For Neck Dissection In The Clinically Negative Neck. Head Neck 33: 1581–1585.
14Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, et al. (2010). Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial. J Clin Oncol 28: 1395-1400.
15Wensing BM, Merkx MA, De Wilde PC, Marres HA, Van den Hoogen FJ (2010) Assessment of preoperative ultrasonography of the neck and elective neck dissection in patients with oral squamous cell carcinoma. Oral Oncol 46:87-91.
16Yuen AP1, Ho CM, Chow TL, Tang LC, Cheung WY, et al. (2009). Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 31: 765-772.
17Okura M, Aikawa T, Sawai NY, Iida S, Kogo M (2009) Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 45: 908–911.
18Keski-Santti H1, Kontio R, Leivo I, Törnwall J, Mätzke S, et al. (2008) Sentinel lymph node biopsy as an alternative to wait and see policy in patients with small T1 oral cavity squamous cell carcinoma. Acta Otolaryngol 128: 98-102.
19Huang SF, Kang CJ, Lin CY, Fan KH, Yen TC, et al. (2008) Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 112: 1066-1075.
20Iype EM, Sebastian P, Mathew A, Balagopal PG, Varghese BT, et al. (2008) The role of selective neck dissection (I–III) in the treatment of node negative (N0) neck in oral cancer. Oral Oncol 44: 1134-1138.
21Borgemeester MC, van den Brekel MW, van Tinteren H, Smeele LE, Pameijer FA, et al. (2008) Ultrasound-guided aspiration cytology for the assessment of the clinically N0 neck: factors influencing its accuracy. Head Neck 30: 1505–1513.
22Capote A, Escorial V, Muñoz-Guerra MF, Rodríguez-Campo FJ, Gamallo C, et al. (2007). Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival? Head Neck 29: 3-11.
23Keski-Säntti H, Atula T, Törnwall J, Koivunen P, Mäkitie A (2006) Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 42: 96–101.
24Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, et al. (2006). Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 24: 4371-4376.
25Wensing BM, Vogel WV, Marres HA, Merkx MA, Postema EJ, et al. (2006) FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 116: 809–813.
26Hart RD, Nasser JG, Trites JR, Taylor SM, Bullock M, et al. (2005) Sentinel lymph node biopsy in N0 squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 131: 34-38.
27Bucur A, Stefanescu L (2004) Management of patients with squamous cell carcinoma of the lower lip and N0-neck. J Craniomaxillofac Surg 32: 16–18.
28Poli T, Massarelli O, Bianchi B, Ferrari S, Corradi D, et al. (2003) Role of intra-operative sentinel lymph node biopsy in oral cavity and oropharynx squamous cell carcinoma: preliminary data. Acta Otorhinolaryngol Ital 23: 305-313.
29Eida S, Sumi M, Yonetsu K, Kimura Y, Nakamura T (2003) Combination of helical CT and Doppler sonography in the follow-up of patients with clinical N0 stage neck disease and oral cancer. AJNR Am J Neuroradiol 24: 312–318.
30Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhoff RH, et al. (2002). Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 24: 282-289.
31Taylor RJ, Wahl RL, Sharma PK, Bradford CR, Terrell JE, et al. (2001) Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 127: 970–974.
32Shoaib T, Soutar DS, MacDonald DG, Camilleri IG, Dunaway DJ, et al. (2001) The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer 91: 2077-2083.
33van den Brekel MW, Reitsma LC, Quak JJ, Smeele LE, van der Linden JC, et al. (1999) Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancer. AJNR Am J Neuroradiol 20:1727–1731.
34Cochrane handbook of for systematic reviews of interventions (2006) 4.2.6 p. 79-91.
35Capote A, Escorial V, Muñoz-Guerra MF, Rodríguez-Campo FJ, Gamallo C, et al. (2007) Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival? Head Neck 29:3–11.
36Lindberg R (1972) Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29:1446-1449.
37Shah JP, Candela FC, Poddar AK (1990) The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 66:109-113.
38Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P (1997) Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck 19:14-19.
39Crean SJ, Hoffman A, Potts J, Fardy MJ (2003) Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV. Head Neck 25:758-762.
40Medina JE, Byers RM (1989) Supraomohyoid neck dissection: rationale, indications, and surgical technique. Head Neck 11:111-122.
41Mathan Mohan, George Paul, Sam Thomas, Mohamed Jaber (2010). Evaluation Of Neck Node Metastasis From Oral Cancer In An Indian Population– A Comparative Pilot Study. Ibnosina J Med BS 2: 14-23.
42Mendenhall WM, Million RR, Cassisi NJ (1986) Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys. 12:733-740.
43Mendenhall WM, Million RR (1986) Elective neck irradiation for squamous cell carcinoma of the head and neck: analysis of time-dose factors and causes of failure. Int J Radiat Oncol Biol Phys 12: 741-746.
44Scharukh Jalisi (2005). Management of the Clinically Negative Neck in Early Squamous Cell Carcinoma of the Oral Cavity. Otolaryngol Clin N Am 38: 37–46.
45Zbaren P, Weidner S, Thoeny HC (2008) Laryngeal and hypopharyngeal carcinomas after (chemo) radiotherapy: a diagnostic dilemma. Curr Opin Otolaryngol Head Neck Surg 16:147-153.
46Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, et al. (1998) Comparison of CT and MR imaging in staging of neck metastases. Radiology 207:123-30.
47Fischbein NJ, Noworolski SM, Henry RG, Kaplan MJ, Dillon WP, et al. (2003) Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. Am J Neuroradiol 24:301-311.
48Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, et al. (2003) Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 24: 1627-1634.
49Rockall AG1, Sohaib SA, Harisinghani MG, Babar SA, Singh N, et al. (2005) Diagnostic performance of nanoparticle enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23: 2813-2821.
50van den Brekel MW1, Castelijns JA, Stel HV, Luth WJ, Valk J, et al. (1991) Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 180:457–461.
51Brouwer J, de Bree R, Comans EF, Castelijns JA, Hoekstra OS, et al. (2004) Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol 261: 479–483.
52Myers LL, Wax MK (1998) Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 27: 342–347.
53Hyde NC, Prvulovich E, Newman L, Waddington WA, Visvikis D, et al. (2003) A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39: 350–360.
54de Bondt RB, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, et al. (2007). Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64: 266-272.
55Alkureishi LW, Burak Z, Alvarez JA, Ballinger J, Bilde A, et al. (2009) Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol 16: 3190–3210.
56Gould EA, Winship T, Philbin PH, Kerr HH (1960) Observations on a ''sentinel node'' in cancer of the parotid. Cancer 13:77–78.
57Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39: 456–466.
58Alex JC, Sasaki CT, Krag DN, Wenig B, Pyle PB (2000) Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma. Laryngoscope 110:198–203.
59Zitsch RP 3rd, Todd DW, Renner GJ, Singh A (2000) Intraoperative radiolymphoscintigraphy for detection of occult nodal metastasis in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 122: 662–666.
60Dünne AA, Külkens C, Ramaswamy A, Folz BJ, Brandt D, et al. (2001) Value of sentinel lymphonodectomy in head and neck cancer patients without evidence of lymphogenic metastatic disease. Auris Nasus Larynx 28: 339–344.
61Taylor RJ, Wahl RL, Sharma PK, Bradford CR, Terrell JE, et al. (2001) Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 127: 970–974.
62Tina Elizabeth Jacob, N Malathi (2013) Sentinel Lymph Node Biopsy in Patients with Oral Cancer. Health Sciences 4: JS004C.
63Leusink FK, van Es RJ, de Bree R, Baatenburg de Jong RJ, van Hooff SR, et al. (2012) Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma. Lancet Oncol 13: e554-e561.
64Hutteman M, Mieog JS, van der Vorst JR, Liefers GJ, Putter H, et al. (2011) Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 127:163–170.
65Hutteman M, van der Vorst JR, Gaarenstroom KN, Peters AA, Mieog JS, et al. (2011) Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol 206: 89. e1-e5.
66Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, et al. (2011) Toward optimization of imaging system and lymphatic tracer for nearinfrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 18: 2483-2489.
67van der Vorst JR, Hutteman M, Gaarenstroom KN, Peters AA, Mieog JS, et al. (2011) Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients. Int J Gynecol Cancer 21:1472–1478.
68Bredell MG (2010) Sentinel lymph node mapping by indocyanin green fluorescence imaging in oopharyngeal cancer – preliminary experience. Head Neck Oncol 2: 31.
69El Ghani F, Van Den Brekel MW, De Goede CJ, Kuik J, Leemans CR, et al. (2002) Shoulder function and patient well-being after various types of neck dissections. Clin Otolaryngol Allied Sci 27: 403–408.
70Flach GB, Bloemena E, van Schie A, Hoekstra OS, van Weert S, et al. (2013) Sentinel node identification in laryngeal cancer: Feasible in primary cancer with previously untreated neck. Oral Oncol 49: 165–168.
71Lang K, Menzin J, Earle CC, Jacobson J, Hsu MA (2004) The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg 130: 1269-1275.
72Lee JM, Turini M, Botteman MF, Stephens JM, Pashos CL (2004) Economic burden of head and neck cancer. A literature review. Eur J Health Econ 5: 70-80.
73St Guily JL, Borget I, Vainchtock A, Rémy V, Takizawa C (2010) Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database. Head Neck Oncol 2: 22.
74van Agthoven M, van Ineveld BM, de Boer MF, Leemans CR, Knegt PP, et al. (2001) The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer 37: 2204-2211.
75Govers TM1, Takes RP, Baris Karakullukcu M, Hannink G, Merkx MA, et al. (2013) Management of the N0 neck in early stage oral squamous cell cancer: A modeling study of the cost-effectiveness. Oral Oncology 49: 771–777.
76Scharukh Jalisi (2005) Management of the Clinically Negative Neck in Early Squamous Cell Carcinoma of the Oral Cavity. Otolaryngol Clin N Am 38: 37–46.
77Weiss MH, Harrison LB, Isaacs RS (1994) Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 120: 699–702.
78Andersen PE, Cambronero E, Shaha AR, Shah JP, et al. (1996) The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 172:689–691.
79Collins SL (1999) Controversies in the management of cancer of the neck. In Comprehensive management of head and neck tumors. 2: 1479-1563.
80Mendenhall WM, Million RR, Cassisi NJ (1980) Elective neck irradiation in squamous cell carcinoma of the head and neck. Head Neck Surg 3:15–20.
81Fletcher GH (1984) Lucy Wortham James Lecture. Subclinical disease. Cancer 53: 1274-1284.
82K Harish (2005) Neck dissections: radical to conservative. World J Surg Oncol 3:21.
83Richtsmeier WJ (2003) Dissecting the "endoscopic neck". Arch Otolaryngol Head Neck Surg 129: 612.
84Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C (2003) Neck disease and distant metastases. Oral Oncol 39: 207-212.
85Leite ICG, Koifman S (1998) Survival analysis in a sample of oral cancer patients at a reference hospital in Rio de Janeiro, Brazil. Oral Oncol 34: 347-352.
86Tiwari R (2000) Squamous cell carcinoma of the superior gingivolabial sulcus. Oral Oncol 36: 461-465.
87O-charoenrat P, Pillai G, Patel S, Ficher C, Archer D, et al. (2003). Tumor thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol 39: 386-390.
88Kiran B Jadhav, Nidhi Gupta (2013) Clinicopathological Prognostic Implicators of Oral Squamous Cell Carcinoma: Need to Understand and Revise. N Am J Med Sci 5: 671–679.
89Vural E, Hutcheson J, Korourian S, Kechelava S, Hanna E (2000) Correlation of neural cell adhesion molecule with perineural spread of squamous cell carcinoma of head and neck. Otolaryngol Head Neck Surg 122:717–720.
90Fagan J, Collins B, Barnes L (1998) Perineural invasion in squamous cell carcinoma of head and neck. Arch Otolaryngol Head Neck Surg 124: 637–640.
91Larsen SR, Johonsen J, Sorensen JA, Krogdahl A (2009) The prognostic significance of histological features in Oral Squamous Cell Carcinoma. J Oral Pathol Med 38: 657–662.
92Wong CY, Helm MA, Kalb RE, Helm TN, Zeitouni NC (2013) The presentation, pathology, and current management strategies of cutaneous metastasis. North Am J Med Sci 5: 499–504.
93Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, et al. (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5: 489-500.
94O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, et al. (2005) Gene expression signature predicts lymphatic me- tastasis in squamous cell carcinoma of the oral cavity. Oncogene 24: 1244-1251.
95Warner GC, Reis PP, Jurisica I, Sultan M, Arora S, et al. (2004) Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 110: 857-868.
96Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, et al. (2005) An expression profile for diagnosis of lymph node me- tastases from primary head and neck squamous cell carcinomas. Nat Genet 37:182-186.
97Roepman P, Kemmeren P, Wessels LF, Slootweg PJ, Holstege FC (2006) Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res 66: 2361-2366.
98van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, et al. (2012) Validation of a Gene Expression Signature for Assessment of Lymph Node Metastasis in Oral Squamous Cell Carcinoma. J Clin Oncol 30: 4104-4110.
99Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, et al. (2004) Follicular lymphoma international prognostic index. Blood 104:1258-1265.
100Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, et al. (2007). The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109: 1857-1861.
101Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, et al. (2009) Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol 16: 159-170.
102Hsieh YY, Mu-Hsin Chang P, Chen MH, Chu PY, Tzeng CH, et al. (2011) Pretreatment risk stratification for non-metastatic head and neck squamous cell carcinoma in a high-prevalence area. Chin Med Assoc 74: 487-492.